Publication:

FDA Oversight of the Tissue Bank Industry

Loading...
Thumbnail Image

Date

2002

Published Version

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

FDA Oversight of the Tissue Bank Industry (2002 Third Year Paper)

Abstract

Until recently, FDA oversight of the human tissue industry has been spotty, even nonexistent. However, industry explosion has forced the FDA to not only publish general industry standards in 1993 (finalized in 1997), but to update those standards with more comprehensive rules that are currently being reviewed. Needless to say, lack of adequate funding has proven problematic for the cash-strapped agency in terms of enforcing any regulations the agency hopes to promulgate.

Description

Other Available Sources

Research Data

Keywords

Food and Drug Law, human, tissue, industry, banking, oversight, regulation

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Related Stories